drugset / Trial / NCT00303017

Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study

NCT00303017

Completed 60 enrolled Primus Pharmaceuticals
RandomizedParallel-groupTriple-blindTreatment

Summary

safety, efficacy and acceptability of Flavocoxid

Timeline

Start
2006-03
Primary completion
2006-07
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naproxen Small molecule 500 mg

Indications